StockData
Pulmatrix, Inc. logo

Pulmatrix, Inc. (PULM) stock

PULMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$1.33+0.04 (+3.10%)

Close on Nov 16, 2026Market cap $4.86MP/E –Yield –

Pulmatrix enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Pulmatrix's enterprise value was $2.62M on Nov 11, 2026, against $11.46M a year earlier. Over the last 5 years it ranged from -$37.38M to $25.09M, with a median of -$9.25M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$2.62M-21.9%
2025Dec 31, 2025$3.35M-77.2%
2024Dec 31, 2024$14.71M–
2023Dec 29, 2023-$14.54M–
2022Dec 30, 2022-$26.56M–
2021Dec 31, 2021-$28.88M-548.6%
2020Dec 31, 2020$6.44M–
2019Dec 31, 2019-$10.68M-243.2%
2018Dec 31, 2018$7.46M-71.7%
2017Dec 29, 2017$26.34M+235.4%
2016Dec 30, 2016$7.85M-83.1%
2015Dec 31, 2015$46.42M+12.5%
2014Dec 31, 2014$41.28M–

More Pulmatrix figures

See a number that looks wrong?